FBRX

$26.44

Pre-MarketAs of Mar 17, 8:00 PM UTC

Forte Biosciences, Inc.

Recent News

Zacks
Feb 25, 2026

Forte Biosciences (FBRX) Upgraded to Buy: Here's What You Should Know

Forte Biosciences (FBRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 18, 2026

We Think Forte Biosciences (NASDAQ:FBRX) Can Afford To Drive Business Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Forte Biosciences...

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Simply Wall St.
Jan 4, 2026

Chief Financial Officer of Forte Biosciences Picks Up 30% More Stock

Investors who take an interest in Forte Biosciences, Inc. ( NASDAQ:FBRX ) should definitely note that the Chief...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Dec 12, 2025

Positive week for Forte Biosciences, Inc. (NASDAQ:FBRX) institutional investors who lost 1.7% over the past year

Key Insights Significantly high institutional ownership implies Forte Biosciences' stock price is sensitive to their...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Sep 11, 2025

We're Hopeful That Forte Biosciences (NASDAQ:FBRX) Will Use Its Cash Wisely

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.